Sarepta Therapeutics, Inc. (LON:0L35)
106.30
-2.69 (-2.47%)
At close: Feb 21, 2025
Sarepta Therapeutics Employees
Sarepta Therapeutics had 1,314 employees as of December 31, 2023. The number of employees increased by 152 or 13.08% compared to the previous year.
Employees
1,314
Change (1Y)
152
Growth (1Y)
13.08%
Revenue / Employee
931.40K GBP
Profits / Employee
69.18K GBP
Market Cap
8.03B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Sarepta Therapeutics News
- 5 days ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 9 days ago - Sarepta closes on $600M revolving credit facility - Seeking Alpha
- 9 days ago - Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility - Business Wire
- 11 days ago - Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results - Business Wire
- 13 days ago - Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics - Business Wire
- 27 days ago - Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYS - Business Wire
- 5 weeks ago - Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely - Seeking Alpha
- 5 weeks ago - Sarepta Therapeutics Inc (SRPT) Reports Strong Preliminary Financial Results for 2024 - GuruFocus